Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

Roche announces $8.3bn acquisition of US biotech firm InterMune

Swiss pharmaceutical firm Roche has announced a "definitive merger agreement" with US firm InterMune, in a deal which will result in its acquisition of the manufacturer of respiratory treatments for a total purchase price of $8.3 billion. 28 Aug 2014

Threat of litigation does not put doctors off innovating, says BMA

The threat of potential legal action from patients does not put doctors off prescribing innovative new treatments, according to the British Medical Association (BMA). 30 Jul 2014

Out-Law Guides

More guides